Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients (ITOHENOX)
NCT01707732Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Nov 2012
- Primary completion
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), sponsored by Rouen University Hospital. Started Nov 2012; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT01707732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01707732.